Literature DB >> 33932328

SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.

Miquel Oliu-Barton1, Bary S R Pradelski2, Philippe Aghion3, Patrick Artus4, Ilona Kickbusch5, Jeffrey V Lazarus6, Devi Sridhar7, Samantha Vanderslott8.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33932328      PMCID: PMC8081398          DOI: 10.1016/S0140-6736(21)00978-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
The trade-off between different objectives is at the heart of political decision making. Public health, economic growth, democratic solidarity, and civil liberties are important factors when evaluating pandemic responses. There is mounting evidence that these objectives do not need to be in conflict in the COVID-19 response. Countries that consistently aim for elimination—ie, maximum action to control SARS-CoV-2 and stop community transmission as quickly as possible—have generally fared better than countries that opt for mitigation—ie, action increased in a stepwise, targeted way to reduce cases so as not to overwhelm health-care systems. We compared COVID-19 deaths, gross domestic product (GDP) growth, and strictness of lockdown measures during the first 12 months of the pandemic for Organisation for Economic Co-operation and Development (OECD) countries that aim for elimination or mitigation (figure ).2, 3, 4 Although all indicators favour elimination, our analysis does not prove a causal connection between varying pandemic response strategies and the different outcome measures. COVID-19 deaths per 1 million population in OECD countries that opted for elimination (Australia, Iceland, Japan, New Zealand, and South Korea) have been about 25 times lower than in other OECD countries that favoured mitigation (figure). Mortality is a proxy for a country's broader disease burden. For example, decision makers should also consider the increasing evidence of long-term morbidities after SARS-CoV-2 infection.
Figure

COVID-19 deaths, GDP growth, and strictness of lockdown measures for OECD countries choosing SARS-CoV-2 elimination versus mitigation

OECD countries opting for elimination are Australia, Iceland, Japan, New Zealand, and South Korea. OECD countries opting for mitigation are Austria, Belgium, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Mexico, the Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, the UK, and the USA. Data on strictness of lockdown measures are from Oxford COVID-19 government response tracker. Data on COVID-19 deaths are from Our World in Data. Data on GDP growth are from OECD Weekly Tracker of economic activity. GDP=gross domestic product. OECD=Organisation for Economic Co-operation and Development.

COVID-19 deaths, GDP growth, and strictness of lockdown measures for OECD countries choosing SARS-CoV-2 elimination versus mitigation OECD countries opting for elimination are Australia, Iceland, Japan, New Zealand, and South Korea. OECD countries opting for mitigation are Austria, Belgium, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Mexico, the Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, the UK, and the USA. Data on strictness of lockdown measures are from Oxford COVID-19 government response tracker. Data on COVID-19 deaths are from Our World in Data. Data on GDP growth are from OECD Weekly Tracker of economic activity. GDP=gross domestic product. OECD=Organisation for Economic Co-operation and Development. There is also increasing consensus that elimination is preferable to mitigation in relation to a country's economic performance. One study quantified the optimal basic reproduction number so that elimination is achieved at minimal economic cost. To this end, consider weekly GDP growth with respect to 2019 for the OECD countries that opted for elimination or mitigation (figure). Elimination is superior to mitigation for GDP growth on average and at almost all time periods. GDP growth returned to pre-pandemic levels in early 2021 in the five countries that opted for elimination, whereas growth is still negative for the other 32 OECD countries. Despite its health and economic advantages, an elimination strategy has been criticised for restricting civil liberties. This claim can be challenged by analysing the stringency index developed by researchers at the University of Oxford. This index measures the strictness of lockdown-style policies that primarily restrict people's behaviour by combining eight indicators of containment and closure policies, eight indicators of health system policies, and one indicator of public information campaigns. Among OECD countries, liberties were most severely impacted in those that chose mitigation, whereas swift lockdown measures—in line with elimination—were less strict and of shorter duration (figure). Importantly, elimination has been framed as a civic solidarity approach that will restore civil liberties the soonest; this focus on common purpose is frequently neglected in the political debate. Evidence suggests that countries that opt for rapid action to eliminate SARS-CoV-2—with the strong support of their inhabitants—also better protect their economies and minimise restrictions on civil liberties compared with those that strive for mitigation. Looking ahead, mass COVID-19 vaccination is key to returning to usual life, but relying solely on COVID-19 vaccines to control the pandemic is risky due to their uneven roll-out and uptake, time-limited immunity, and the emergence of new SARS-CoV-2 variants.8, 9 History shows that vaccination alone can neither single-handedly nor rapidly control a virus and that a combination of public health measures are needed for containment. The eradication of smallpox required concerted, decades-long efforts, including vaccination; communication and public engagement; and test, trace, and isolate measures. Even at the end of vaccination campaigns, such public health measures must be maintained to some extent or new waves of infections might lead to increased morbidity and mortality. With the proliferation of new SARS-CoV-2 variants of concern, many scientists are calling for a coordinated international strategy to eliminate SARS-CoV-2.12, 13, 14, 15 Moreover, the US Department of State declared in April, 2021, that stopping COVID-19 is the Biden–Harris administration's number one priority and highlighted that “this pandemic won't end at home until it ends worldwide”. National action alone is insufficient and a clear global plan to exit the pandemic is necessary. Countries that opt to live with the virus will likely pose a threat to other countries, notably those that have less access to COVID-19 vaccines. The uncertainty of lockdown timing, duration, and severity will stifle economic growth as businesses withhold investments and consumer confidence deteriorates. Global trade and travel will continue to be affected. Political indecisiveness and partisan policy decisions reduce trust in government. This does not bode well in those countries that have seen a retraction of democracy. Meanwhile, countries opting for elimination are likely to return to near normal: they can restart their economies, allow travel between green zones, and support other countries in their vaccination campaigns and beyond. The consequences of varying government COVID-19 responses will be long-lasting and extend beyond the end of the pandemic. Early economic and political gains made by countries aiming to eliminate SARS-CoV-2 will probably pay off in the long run.
  11 in total

1.  Reflections on the eradication of smallpox.

Authors:  Sanjoy Bhattacharya
Journal:  Lancet       Date:  2010-05-08       Impact factor: 79.321

2.  A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker).

Authors:  Thomas Hale; Noam Angrist; Rafael Goldszmidt; Beatriz Kira; Anna Petherick; Toby Phillips; Samuel Webster; Emily Cameron-Blake; Laura Hallas; Saptarshi Majumdar; Helen Tatlow
Journal:  Nat Hum Behav       Date:  2021-03-08

3.  Five reasons why COVID herd immunity is probably impossible.

Authors:  Christie Aschwanden
Journal:  Nature       Date:  2021-03       Impact factor: 49.962

4.  Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases.

Authors:  Michael G Baker; Nick Wilson; Tony Blakely
Journal:  BMJ       Date:  2020-12-22

5.  SARS-CoV-2 variants and ending the COVID-19 pandemic.

Authors:  Arnaud Fontanet; Brigitte Autran; Bruno Lina; Marie Paule Kieny; Salim S Abdool Karim; Devi Sridhar
Journal:  Lancet       Date:  2021-02-11       Impact factor: 79.321

6.  COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II.

Authors:  Daniel Freeman; Bao S Loe; Andrew Chadwick; Cristian Vaccari; Felicity Waite; Laina Rosebrock; Lucy Jenner; Ariane Petit; Stephan Lewandowsky; Samantha Vanderslott; Stefania Innocenti; Michael Larkin; Alberto Giubilini; Ly-Mee Yu; Helen McShane; Andrew J Pollard; Sinéad Lambe
Journal:  Psychol Med       Date:  2020-12-11       Impact factor: 7.723

7.  Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections.

Authors:  Viola Priesemann; Melanie M Brinkmann; Sandra Ciesek; Sarah Cuschieri; Thomas Czypionka; Giulia Giordano; Deepti Gurdasani; Claudia Hanson; Niel Hens; Emil Iftekhar; Michelle Kelly-Irving; Peter Klimek; Mirjam Kretzschmar; Andreas Peichl; Matjaž Perc; Francesco Sannino; Eva Schernhammer; Alexander Schmidt; Anthony Staines; Ewa Szczurek
Journal:  Lancet       Date:  2020-12-18       Impact factor: 79.321

8.  Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.

Authors:  Sam Moore; Edward M Hill; Michael J Tildesley; Louise Dyson; Matt J Keeling
Journal:  Lancet Infect Dis       Date:  2021-03-18       Impact factor: 25.071

9.  An action plan for pan-European defence against new SARS-CoV-2 variants.

Authors:  Viola Priesemann; Rudi Balling; Melanie M Brinkmann; Sandra Ciesek; Thomas Czypionka; Isabella Eckerle; Giulia Giordano; Claudia Hanson; Zdenek Hel; Pirta Hotulainen; Peter Klimek; Armin Nassehi; Andreas Peichl; Matjaz Perc; Elena Petelos; Barbara Prainsack; Ewa Szczurek
Journal:  Lancet       Date:  2021-01-21       Impact factor: 79.321

10.  Preparing democracies for pandemics.

Authors:  Thomas J Bollyky; Ilona Kickbusch
Journal:  BMJ       Date:  2020-10-23
View more
  32 in total

Review 1.  The Lancet Commission on lessons for the future from the COVID-19 pandemic.

Authors:  Jeffrey D Sachs; Salim S Abdool Karim; Lara Aknin; Joseph Allen; Kirsten Brosbøl; Francesca Colombo; Gabriela Cuevas Barron; María Fernanda Espinosa; Vitor Gaspar; Alejandro Gaviria; Andy Haines; Peter J Hotez; Phoebe Koundouri; Felipe Larraín Bascuñán; Jong-Koo Lee; Muhammad Ali Pate; Gabriela Ramos; K Srinath Reddy; Ismail Serageldin; John Thwaites; Vaira Vike-Freiberga; Chen Wang; Miriam Khamadi Were; Lan Xue; Chandrika Bahadur; Maria Elena Bottazzi; Chris Bullen; George Laryea-Adjei; Yanis Ben Amor; Ozge Karadag; Guillaume Lafortune; Emma Torres; Lauren Barredo; Juliana G E Bartels; Neena Joshi; Margaret Hellard; Uyen Kim Huynh; Shweta Khandelwal; Jeffrey V Lazarus; Susan Michie
Journal:  Lancet       Date:  2022-09-14       Impact factor: 202.731

2.  A comparison of 2020 health policy responses to the COVID-19 pandemic in Canada, Ireland, the United Kingdom and the United States of America.

Authors:  Lynn Unruh; Sara Allin; Greg Marchildon; Sara Burke; Sarah Barry; Rikke Siersbaek; Steve Thomas; Selina Rajan; Andriy Koval; Mathew Alexander; Sherry Merkur; Erin Webb; Gemma A Williams
Journal:  Health Policy       Date:  2021-07-01       Impact factor: 3.255

3.  Projected all-cause deaths attributable to COVID-19-related unemployment in Croatia in 2020.

Authors:  S Handanagic; R Muzic; I Bozicevic; S Oreskovic
Journal:  Public Health       Date:  2022-04-27       Impact factor: 4.984

4.  The new normal: Covid-19 risk perceptions and support for continuing restrictions past vaccinations.

Authors:  Maja Graso
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.752

5.  Challenges in evaluating risks and policy options around endemic establishment or elimination of novel pathogens.

Authors:  C Jessica E Metcalf; Soa Fy Andriamandimby; Rachel E Baker; Emma E Glennon; Katie Hampson; T Deirdre Hollingsworth; Petra Klepac; Amy Wesolowski
Journal:  Epidemics       Date:  2021-11-17       Impact factor: 4.396

6.  Assessment of Coronavirus Disease 2019 Intervention Strategies in the Nordic Countries Using Genomic Epidemiology.

Authors:  Sebastian Duchene; Leo Featherstone; Birgitte Freiesleben de Blasio; Edward C Holmes; Jon Bohlin; John H O Pettersson
Journal:  Open Forum Infect Dis       Date:  2022-01-03       Impact factor: 3.835

Review 7.  Open science communication: The first year of the UK's Independent Scientific Advisory Group for Emergencies.

Authors:  Martin McKee; Danny Altmann; Anthony Costello; Karl Friston; Zubaida Haque; Kamlesh Khunti; Susan Michie; Tolullah Oni; Christina Pagel; Deenan Pillay; Steve Reicher; Helen Salisbury; Gabriel Scally; Kit Yates; Linda Bauld; Laura Bear; John Drury; Melissa Parker; Ann Phoenix; Elizabeth Stokoe; Robert West
Journal:  Health Policy       Date:  2022-01-15       Impact factor: 3.255

8.  Pathways and obstacles to social recovery following the elimination of SARS-CoV-2 from Aotearoa New Zealand: a qualitative cross-sectional study.

Authors:  Nicholas J Long; Nayantara Sheoran Appleton; Sharyn Graham Davies; Antje Deckert; Edmond Fehoko; Eleanor Holroyd; Nelly Martin-Anatias; Rogena Sterling; Susanna Trnka; Laumua Tunufa'i
Journal:  J Public Health (Oxf)       Date:  2022-01-07       Impact factor: 2.341

9.  The policy art of the "trade-off" for combatting COVID-19.

Authors:  Jong-Koo Lee
Journal:  Osong Public Health Res Perspect       Date:  2021-06-24

10.  Green zoning: An effective policy tool to tackle the Covid-19 pandemic.

Authors:  Miquel Oliu-Barton; Bary S R Pradelski
Journal:  Health Policy       Date:  2021-06-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.